Long-term Variability of Desmosine/Isodesmosine as Biomarker in Alpha-1-antritrypsin Deficiency–related COPD

Author： Fregonese Laura Ferrari Fabio Fumagalli Marco Luisetti Maurizio Stolk Jan Iadarola Paolo

ISSN： 1541-2555

Source： COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol.8, Iss.5, 2011-09, pp. : 329-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Desmosine and isodesmosine are products of elastin breakdown which are candidate biomarkers to measure lung destruction in COPD. Data exist on the burden of desmosines in urine and plasma in COPD but long-term changes have never been investigated. We determined the changes of desmosine levels over 14 months in urine and plasma of patients with type ZZ alpha-1-antitryspsin deficiency-related COPD. Urines and plasma for determination of desmosines were collected from 11 ex-smokers with moderate/severe emphysema at monthly intervals for 14 months. Spirometry and gas transfer were assessed at baseline and 6-month intervals. At baseline and month 14, eleven healthy partners of patients volunteered to give a blood sample for detection of desmosines. Desmosines were determined by capillary electrophoresis combined with laser-induced fluorescence. Urine and plasma desmosines were significantly increased after 14 months in patients (p == 0.027 and p == 0.0005, respectively). Plasma desmosines of healthy partners at baseline were 4-fold lower than from patients and not significantly different from values at month 14. Only a significant decline in lung gas transfer occurred in patients (p == 0.015). The variability of desmosines was higher in urine than in plasma (coefficient of variation 0.17 and 0.087, respectively). As longitudinal desmosine changes likely reflect the elevated elastic fiber turnover associated with the progression of lung damage and destruction in COPD, they appear to be a suitable marker for application in long-term studies. Plasma desmosines were more stable long-term biomarkers than desmosines in urine.

Related content

Recent advances in α-1-antitrypsin deficiency-related lung disease

By Brebner Judith A Stockley Robert A

Expert Review of Respiratory Medicine, Vol. 7, Iss. 3, 2013-06 ,pp. : 213-230 (18)

Informa Healthcare

Access to resources Recommend Favorite

Asthma and COPD in Alpha-1 Antitrypsin Deficiency. Evidence for the Dutch Hypothesis

By Eden Edward

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 5, 2010-09 ,pp. : 366-374 (9)

Informa Healthcare

Access to resources Recommend Favorite

Differences in Adjustment between Individuals with Alpha-1 Antitrypsin Deficiency (AATD)-Associated COPD and Non-AATD COPD

By Holm Kristen E. Borson Soo

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 2, 2013-03 ,pp. : 226-234 (9)

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Effects of Budesonide on Inflammatory Status in COPD

By Boorsma M. Lutter R. van de Pol M. A. Out T. A. Jansen H. M. Jonkers R. E.

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 5, Iss. 2, 2008-04 ,pp. : 97-104 (8)

Informa Healthcare

Access to resources Recommend Favorite

Alcohol Use Predicts ER Visits in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) Associated COPD

By Hoth Karin F. Ford Dee W. Sandhaus Robert A. Strange Charlie Wamboldt Frederick S. Holm Kristen E.

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 4, 2012-07 ,pp. : 417-425 (9)

Informa Healthcare

Access to resources Recommend Favorite